Anaphylaxis
Anaphylaxis wani mummunan rashin lafiyar da ke saurin farawa kuma yana iya haifar da mutuwa.[4][5] Yawanci yana haifar da fiye da ɗaya daga cikin masu zuwa: kumburin ƙaiƙayi, kumburin makogwaro ko harshe, gajeriyar numfashi, amai, haske, da ƙarancin hawan jini.[4] Waɗannan alamomin yawanci suna zuwa sama da mintuna zuwa sa'o'i.[4]
| Anaphylaxis | |
|---|---|
 | |
Description (en)  | |
| Iri |
hypersensitivity (en) , allergic response (en) side effect (en) |
| Specialty (en) |
emergency medicine (en) immunology (en) |
| Medical treatment (en) | |
| Magani |
epinephrine (en) |
| Identifier (en) | |
| ICD-10 | T78.2 |
| ICD-9 | 995.0 |
| DiseasesDB | 29153 |
| MedlinePlus | 000844 |
| eMedicine | 000844 |
| MeSH | D000707 |
| Anaphylaxis | |
|---|---|
| Other names: Anaphylactoid, anaphylactic shock | |
|
| |
| Angioedema na fuska wanda yaron ba zai iya buɗe idanunsa ba. Wannan abin da ya faru ya faru ne sakamakon bayyanar alerji | |
 | |
| Specialty | Allergy da immunology |
| Symptoms | Ƙunƙarar ƙaiƙayi, kumburin makogwaro, ƙarancin numfashi, haske,[1] |
| Usual onset | Fiye da mintuna zuwa sa'o'i[1] |
| Causes | Cizon kwari, abinci, magunguna[1] |
| Diagnostic method | Bisa ga alamu[2] |
| Differential diagnosis | Allergic halayen, angioedema, asma exacerbation, carcinoid ciwo[2] |
| Treatment | Epinephrine, ruwan jijiya[1] |
| Frequency | 0.05–2%[3] |
Dalilan da aka fi sani sun haɗa da cizon kwari da ƙwari, abinci, da magunguna.[4] Wasu dalilai sun haɗa da bayyanar latex da motsa jiki.[4] Bugu da ƙari, lokuta na iya faruwa ba tare da wani dalili na musamman ba.[4] Tsarin ya ƙunshi sakin masu shiga tsakani daga wasu nau'ikan farin jini waɗanda ke haifar da ko dai tsarin rigakafi ko marasa rigakafi.[6] Bincike ya dogara ne akan bayyanar cututtuka da alamun bayyanar bayan bayyanar da rashin lafiyar.[4]
Babban maganin anaphylaxis shine allurar epinephrine a cikin tsoka, ruwan jijiya, da sanya mutum lebur.[4][7] Ana iya buƙatar ƙarin allurai na epinephrine.[4] Sauran matakan, irin su antihistamines da steroids, sun dace.[4] Ɗaukar epinephrine autoinjector da ganewa game da yanayin ana ba da shawarar ga mutanen da ke da tarihin anaphylaxis.[4]
A duk duniya, an kiyasta 0.05-2% na yawan jama'a suna fuskantar anaphylaxis a wani matsayi na rayuwa.[6] Da alama farashin yana ƙaruwa.[6] Yana faruwa sau da yawa a cikin matasa da mata.[7][8] Na mutanen da ke zuwa asibiti masu fama da anaphylaxis a Amurka kusan kashi 99.7 cikin ɗari suna rayuwa.[9] Kalmar ta fito daga Tsohuwar Hellenanci: ἀνά, romanized: ana, lit. 'da', da Tsohon Girkanci: φύλαξις, romanized: phylaxis, lit. 'kariya'.[10]
Manazarta
gyara sashe- ↑ 1.0 1.1 1.2 1.3 "Anaphylaxis". National Institute of Allergy and Infectious Diseases. April 23, 2015. Archived from the original on 4 May 2015. Retrieved 4 February 2016.
- ↑ 2.0 2.1 Caterino, Jeffrey M.; Kahan, Scott (2003). In a Page: Emergency medicine (in Turanci). Lippincott Williams & Wilkins. p. 132. ISBN 9781405103572. Archived from the original on 2017-09-08.
- ↑ Simons, FE; Ardusso, LR; Bilò, MB; El-Gamal, YM; Ledford, DK; Ring, J; Sanchez-Borges, M; Senna, GE; Sheikh, A; Thong, BY; World Allergy, Organization. (February 2011). "World allergy organization guidelines for the assessment and management of anaphylaxis". The World Allergy Organization Journal. 4 (2): 13–37. doi:10.1097/wox.0b013e318211496c. PMC 3500036. PMID 23268454.
- ↑ 4.00 4.01 4.02 4.03 4.04 4.05 4.06 4.07 4.08 4.09 4.10 Sampson HA, Muñoz-Furlong A, Campbell RL, et al. (February 2006). "Second symposium on the definition and management of anaphylaxis: summary report—Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium". The Journal of Allergy and Clinical Immunology. 117 (2): 391–7. doi:10.1016/j.jaci.2005.12.1303. PMID 16461139.
- ↑ Tintinalli, Judith E. (2010). Emergency Medicine: A Comprehensive Study Guide (Emergency Medicine (Tintinalli)). New York: McGraw-Hill Companies. pp. 177–182. ISBN 978-0-07-148480-0.
- ↑ 6.0 6.1 6.2 Khan, BQ; Kemp, SF (August 2011). "Pathophysiology of anaphylaxis". Current Opinion in Allergy and Clinical Immunology. 11 (4): 319–25. doi:10.1097/ACI.0b013e3283481ab6. PMID 21659865.
- ↑ 7.0 7.1 The EAACI Food Allergy and Anaphylaxis Guidelines Group (August 2014). "Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology". Allergy. 69 (8): 1026–45. doi:10.1111/all.12437. PMID 24909803.
- ↑ Lee, JK; Vadas, P (July 2011). "Anaphylaxis: mechanisms and management". Clinical and Experimental Allergy. 41 (7): 923–38. doi:10.1111/j.1365-2222.2011.03779.x. PMID 21668816.
- ↑ Ma, L; Danoff, TM; Borish, L (April 2014). "Case fatality and population mortality associated with anaphylaxis in the United States". The Journal of Allergy and Clinical Immunology. 133 (4): 1075–83. doi:10.1016/j.jaci.2013.10.029. PMC 3972293. PMID 24332862.
- ↑ Gylys, Barbara (2012). Medical Terminology Systems: A Body Systems Approach. F.A. Davis. p. 269. ISBN 9780803639133. Archived from the original on 2016-02-05.